GTS Securities’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,600
Closed -$6.56M 3859
2024
Q3
$6.56M Sell
10,600
-5,200
-33% -$3.08M 0.01% 725
2024
Q2
$8.74M Sell
15,800
-800
-5% -$458K 0.02% 557
2024
Q1
$9.65M Sell
16,600
-37,200
-69% -$20.9M 0.02% 528
2023
Q4
$28.6M Buy
53,800
+8,100
+18% +$3.92M 0.05% 235
2023
Q3
$23.1M Buy
+45,700
New +$24.4M 0.04% 290

Other funds holding TMO

GTS Securities's TMO Position: Q1 2026 in Review

GTS Securities reduced its Thermo Fisher Scientific (TMO) stake by 69% in Q1 2026, selling an estimated $1.43M and leaving 1,198 shares worth $589K. The position accounts for 0.02% of the portfolio, ranked #654.

GTS Securities first reported a position in TMO in Q3 2023 and has held it in 11 quarters since. The position peaked at $3.76M in Q4 2023. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • GTS Securities held 1,198 shares of Thermo Fisher Scientific worth $589K as of Q1 2026.
  • GTS Securities sold 2,633 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.43M.
  • Thermo Fisher Scientific made up 0.02% of GTS Securities's portfolio in Q1 2026, its #654 holding.
  • GTS Securities first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 11 quarters since.
  • GTS Securities's Thermo Fisher Scientific position peaked at $3.76M in Q4 2023.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.